drugset / Trial / NCT00796991
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this clinical research study is to learn the pharmacokinetics of Ipilimumab when combined with Paclitaxel/Carboplatin or Dacarbazine
Timeline
- Start
- 2009-02
- Primary completion
- 2009-11
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carboplatin | Small molecule | 6 unknown | Intravenous |
| Comparator | Dacarbazine | Small molecule | 850 mg/m2 | Intravenous |
| Comparator | Ipilimumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Comparator | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |